Xolair 150MG/ML SYR 1S
Ended Awarded
- Contract number
- SPE2DX25FWPKJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,161
Award facts
- Contract value 100% obligated
- $2,161.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded July 28, 2025, to AmerisourceBergen Drug Corp represents a competitively awarded, non-set-aside contract for the procurement of XOLAIR 150MG/ML syringes with a ceiling value of $2,161.05. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. XOLAIR (omalizumab) is a monoclonal antibody therapy used to treat moderate-to-severe allergic asthma and other allergic conditions, representing a specialized pharmaceutical product within the Defense health system's medical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts and serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms designed to support the Department of Defense's pharmaceutical and medical supply needs.
Quick answers
Who was awarded contract SPE2DX25FWPKJ?
SPE2DX25FWPKJ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 28, 2025.
How much is contract SPE2DX25FWPKJ worth?
The government has obligated $2,161 on SPE2DX25FWPKJ.
Is contract SPE2DX25FWPKJ an order under another contract?
Yes. SPE2DX25FWPKJ is a delivery order under SPE2DX15D6028, an indefinite delivery contract.
Was contract SPE2DX25FWPKJ competed?
The extent of competition for SPE2DX25FWPKJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award